https://pubmed.ncbi.nlm.nih.gov/22433803/
[Ceraxon (citicoline) in the treatment of the mild cognitive impairment syndrome]
The objective was to study efficacy and safety of ceraxon (citicoline) used perorally in dose 1000 mg daily in the treatment of cognitive disturbances in...
mild cognitive impairmentin theciticolinetreatmentsyndrome